148 related articles for article (PubMed ID: 22142668)
1. Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.
Di Minno MN; Lupoli R; Palmieri NM; Russolillo A; Buonauro A; Di Minno G
Thromb Res; 2012 Mar; 129(3):341-4. PubMed ID: 22142668
[TBL] [Abstract][Full Text] [Related]
2. Aspirin resistance and platelet turnover: a 25-year old issue.
Di Minno G
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):542-5. PubMed ID: 21745731
[TBL] [Abstract][Full Text] [Related]
3. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
6. Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.
Klein PS
Diabetes; 2008 May; 57(5):e10; author reply e11. PubMed ID: 18443367
[No Abstract] [Full Text] [Related]
7. Aspirin resistance and diabetic angiopathy: back to the future.
Di Minno G; Violi F
Thromb Res; 2004; 113(2):97-9. PubMed ID: 15115664
[No Abstract] [Full Text] [Related]
8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
9. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
[TBL] [Abstract][Full Text] [Related]
10. Aspirin resistance and compliance with therapy.
Dawson J; Quinn T; Rafferty M; Higgins P; Ray G; Lees KR; Walters MR
Cardiovasc Ther; 2011 Oct; 29(5):301-7. PubMed ID: 20553280
[TBL] [Abstract][Full Text] [Related]
11. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
[TBL] [Abstract][Full Text] [Related]
12. [Aspirin resistance].
Yilmaz MB; Balbay Y; Korkmaz S
Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
[TBL] [Abstract][Full Text] [Related]
13. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
14. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
15. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
17. Towards a definition of aspirin resistance: a typological approach.
Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
[TBL] [Abstract][Full Text] [Related]
18. Trial of repeated low-dose aspirin in diabetic angiopathy.
DiMinno G; Silver MJ; Cerbone AM; Murphy S
Blood; 1986 Oct; 68(4):886-91. PubMed ID: 3092890
[TBL] [Abstract][Full Text] [Related]
19. Functional testing methods for the antiplatelet effects of aspirin.
Schrör K; Huber K; Hohlfeld T
Biomark Med; 2011 Feb; 5(1):31-42. PubMed ID: 21319963
[TBL] [Abstract][Full Text] [Related]
20. Aspirin resistance.
Tran HA; Anand SS; Hankey GJ; Eikelboom JW
Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
